瀚源生醫與伊利諾大學香檳分校Bashir教授的實驗室合作
The very first of its kind commercial semiconductor field-effect transistor (FET) biosensor platform donated from Helios Bioelectronics Inc to collaborators at the Laboratory of Integrated Biomedical Micro/Nanotechnology & Applications, University of Illinois at Urbana-Champaign (LIBNA@UIUC). From left: Enrique Valera, Justin Liang, Yi-Shao Liu, Rashid Bashir, Katherine Koprowski, Janice Baek, Jongwon Lim.
Paving the way for your ideal Biomarkers
The BioFET (field-effect transistor) platform can detect any target with a net charge including nucleic acids (e.g. miRNA), proteins, bacteria, cells, etc. The BioFET chips are customizable through immobilization of target-specific probes onto the chip surface. Minimal sample preparation is required and no labeling is necessary for target detection. Over one million biosensors are contained on a single BioFET chip the size of a fingertip. This allows for detection of multiple targets on a single BioFET chip with significant statistical power.
POCT Empowered with Portable-sized BioFET Device
Fig.1. Discover the science behind the BioFET platform and its advantages in less than 2 min!
A strategic partnership and collaboration between Helios Bioelectronics Inc. and the Laboratory of Integrated Biomedical Micro/Nanotechnology & Applications (LIBNA), University of Illinois at Urbana-Champaign (UIUC)
Fig. 2. The BioFET platform developed by Helios Bioelectronics Inc. A semiconductorbiosensor can be used for detection of various kinds of biological molecules.
其他相關訊息
-
媒體報導16.Aug.2023瀚源獲得第19屆國家新創獎-企業新創組
-
媒體報導23.Aug.2022董事長接受The Silicon Review訪問
-
媒體報導13.Jun.2022瀚源生醫董事長接受環球生技月刊專訪